Effect of metformin treatment on ovarian stromal blood flow in women with polycystic ovary syndrome
Abstract
Objective The aim was to study the effect of metformin treatment on ovarian stromal blood flow in women with polycystic ovary syndrome (PCOS). Background PCOS is an endocrine disorder that affects mostly women of reproductive age. Metformin has positive biochemical effects in PCOS patients' therapy. Patients and methods A case–control study was conducted on 98 women who were divided into: group I which included 49 infertile women with PCOS and group II which included 49 fertile women without PCOS. All patients attended the Obstetrics and Gynecology Outpatient Clinic at Menoufia University Hospitals and Tala General Hospital, Egypt, from April to November 2017. Detailed history, clinical examination, routine baseline investigations, and Doppler flow were done. Results There was a statistically significant difference between the studied groups regarding weight, BMI, follicle-stimulating hormone, and Doppler post-treatment resistance and pulsatility indices (left, right). There was a statistically highly significant difference (P ≤ 0.001) regarding Doppler posttreatment resistance and pulsatility indices (left, right) before and after metformin treatment. Also, a nonsignificant correlation was recorded between Doppler resistance and pulsatility indices (left, right) and age, weight, BMI, follicle-stimulating hormone (mIU/ml), and luteinizing hormone (mIU/ml) in the patients group after metformin treatment. Conclusion Metformin has a beneficial effect in women with PCOS via…
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.